The size of the Single-Cell Analysis Market in the Asia Pacific is estimated to grow USD 0.74 billion by 2024 from USD 0.33 billion in 2019. This market is forecasted to grow at a CAGR of 17.92% from 2019 to 2024.
The single-cell analysis market is emerging as one that has attracted investors’ interest. The market itself began to take shape after evidence emerged that within small populations of cells, heterogeneity was observed. Further research in the area today has helped biologists learn about the gene expression profiles in cells.
Because individual cells can differ vastly in terms of their protein levels, size, and expressed RNA transcripts, the single-cell analysis could provide the answers to breakthrough treatments in cancer research, stem cell biology, and much more. Research-based on the assumption that cell populations are homogenous can be misleading and often leaves out essential changes in single cells, and this is why single-cell analysis is relevant.
The single-cell analysis market is driven by factors such as the increasing government funding for cell-based research and the growth in the biotechnological and pharmaceutical industries. Other factors include the scope of single-cell analysis in cancer research and the growing focus on personalized medicine as consumers become more aware of the advances in the medical field. As for the constraints of the market, the numerous regulations that exist to protect the intellectual property of people hampers the market. The protests by NGOs against the unrestricted use of assay kits citing intellectual property encroachment is another reason for the hindered growth of the market.
This research report has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2025.
Regionally, the Asia Pacific single-cell analysis market is growing at a significant rate due to the rising cancer research and the use of single-cell sequencing processes and the development of innovative modalities.
The India single-cell analysis market is expected to grow significantly over the forecast period. In previous years the Indian government has introduced a program ASHD Program to operate the applications of stem cell technology in human disorders. Also, the biotechnology and pharmaceutical, national laboratories are getting more funding from the government for research like stem cells in diagnostic and therapeutic, which will further have an impact on the regional Single-cell analysis Market. The expanding technological innovations, growing biotechnology and pharmaceutical industry in the region, and the rising prevalence of transmittable infections across the region are the main responsible factors for the growth of the Asia Pacific single-cell analysis market.
Chinese single-cell analysis market is ruling with dominant shares of the market from past years and is also expected to continue the same growth rate in the coming years. Increasing geriatric population is one of the major factors fuelling the demand of the market.
Companies playing a prominent role in the Asia Pacific Single-Cell Analysis Market Profiled in the Report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Cell
5.1.1 Introduction
5.1.2 Human Cells
5.1.3 Animal Cells
5.1.4 Microbial Cells
5.1.5 Y-o-Y Growth Analysis, By Cell
5.1.6 Market Attractiveness Analysis, By Cell
5.1.7 Market Share Analysis, By Cell
5.2 Products
5.2.1 Introduction
5.2.2 Consumables
5.2.3 Instruments
5.2.4 Y-o-Y Growth Analysis, By Products
5.2.5 Market Attractiveness Analysis, By Products
5.2.6 Market Share Analysis, By Products
5.3 Techniques
5.3.1 Introduction
5.3.2 Flow Cytometry
5.3.3 NGS
5.3.4 PCR
5.3.5 Microscopy
5.3.6 Mass Spectrometry
5.3.7 Other Techniquess
5.3.8 Y-o-Y Growth Analysis, By Techniques
5.3.9 Market Attractiveness Analysis, By Techniques
5.3.10 Market Share Analysis, By Techniques
5.4 Applications
5.4.1 Introduction
5.4.2 Research Application
5.4.3 Medical Application
5.4.4 Y-o-Y Growth Analysis, By Applications
5.4.5 Market Attractiveness Analysis, By Applications
5.4.6 Market Share Analysis, By Applications
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Cell
6.1.3.3 By Products
6.1.3.4 By Techniques
6.1.3.5 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Cell
6.1.4.3 By Products
6.1.4.4 By Techniques
6.1.4.5 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Cell
6.1.5.3 By Products
6.1.5.4 By Techniques
6.1.5.5 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five Analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Danaher Corporation
8.1.1 Overview
8.1.2 Cell Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA
8.3 Becton
8.4 Dickinson and Company
8.5 Promega Corporation
8.6 General Electric Company
8.7 Thermo Fisher Scientific
8.8 Miltenyi Biotec
8.9 Illumina
8.10 Bio-Rad Laboratories
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
